Alex Cohen calls the NYT-style narrative of a two-person startup selling billions in compounded GLP-1s implausible, citing regulatory and peptide-market realities.
I can guarantee you this story is completely full of shit.
There is zero chance a two person startup is selling $2b worth of compounded GLP1s.
And given the state of peptides, if this were true, the last thing you’d do is brag
This finding is one of many signals tracked across Indiehacking. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Indiehacking